Advisory Board
COO / Co-Founder, Snakker
He started Snakker because he saw pharma spending millions on content that nobody engaged with.
Static PDFs sent to doctors who'd already stopped reading. Campaigns that took four months to launch and delivered zero insight back to the brand team. AI tools that generated more content faster - but not better content.
Snakker was built to fix that. We create interactive content experiences for the life science industry — campaigns that adapt to how healthcare professionals actually behave, and feed real engagement intelligence back into strategy. Not AI for the sake of AI. AI that collapses the timeline between approved content and launched campaign, and turns every interaction into a data point the brand team can act on.
Today, they work with 10+ global pharmaceutical brands across 26 countries. Their platform powers campaigns for products at every stage - from blockbuster launches to legacy brands that haven't had proper marketing support in years.
What drives him: proving that AI in pharma doesn't have to mean chatbots and auto-generated email subject lines. It means fundamentally rethinking how content is produced, delivered, and measured - with the rigour this industry demands.
He writes about this every week in Pixel & Pitch, his newsletter on AI, pharma marketing, and what's actually working vs. what's just hype.